Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

0.7026
Delayed Data
As of Aug 12
 -0.032 / -4.36%
Today’s Change
0.49
Today|||52-Week Range
1.85
-38.37%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +398.15% increase from the last price of 0.70.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$0.00
Reporting Date
Aug 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -33.33%
 
 
 
 
 
 
Growthannually -4.26%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.